Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

28.7K
Overview
28.7K
Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Active versus Passive Immunity01:31

Active versus Passive Immunity

8.6K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
8.6K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K
Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Vaccines01:21

Vaccines

98
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
98

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sympatric Occurrence of Five Exophilic Tick Species in the Levice Region (Southwestern Slovakia) and Their Infection with Tick-Borne Pathogens.

Pathogens (Basel, Switzerland)·2026
Same author

Editorial: Skin - confluence of vertebrate host defences, arthropod vectors, and vector-borne pathogens.

Frontiers in immunology·2025
Same author

Living with ticks: Results of an online survey of the knowledge, attitudes and practices (KAP) regarding ticks and tick-borne pathogens in academic environments across Europe.

Ticks and tick-borne diseases·2025
Same author

Generation of Ticks Infected with Tick-Borne Encephalitis Virus.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Long-Term Dynamics of SARS-CoV-2 Variant-Specific Neutralizing Antibodies Following mRNA Vaccination and Infection.

Viruses·2025
Same author

Surveillance of tick-borne encephalitis virus foci in Slovakia: A seroprevalence study in ruminants combined with virus detection in ticks.

Ticks and tick-borne diseases·2025

Related Experiment Video

Updated: May 5, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.0K

An antivector vaccine protects against a lethal vector-borne pathogen.

Milan Labuda1, Adama R Trimnell, Martina Licková

  • 1Institute of Zoology, Slovak Academy of Sciences, Bratislava, Slovakia.

Plos Pathogens
|April 11, 2006
PubMed
Summary

An anti-tick vaccine targeting Rhipicephalus appendiculatus cement protein (64TRP) protected mice against tick-borne encephalitis virus (TBEV). This novel vaccine disrupts tick feeding and causes tick death, offering a new strategy for vector-borne disease control.

More Related Videos

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

14.1K
Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

6.3K

Related Experiment Videos

Last Updated: May 5, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.0K
A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

14.1K
Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
06:02

Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors

Published on: September 13, 2018

6.3K

Area of Science:

  • Veterinary immunology
  • Parasitology
  • Infectious diseases

Background:

  • Vaccines targeting disease vectors like ticks can prevent vector-borne diseases.
  • Rhipicephalus appendiculatus is a significant tick vector.
  • Tick-borne encephalitis virus (TBEV) is a major public health concern.

Purpose of the Study:

  • To evaluate the efficacy of a novel anti-tick vaccine based on Rhipicephalus appendiculatus cement protein (64TRP) against TBEV transmission in mice.
  • To assess the vaccine's dual action on tick feeding and survival.
  • To compare the vaccine's performance against a commercial TBEV vaccine and an anti-tick vaccine (TickGARD).

Main Methods:

  • Mice were immunized with a 64TRP vaccine derived from Rhipicephalus appendiculatus.
  • Vaccinated and control mice were infested with infected Ixodes ricinus ticks carrying TBEV.
  • Key parameters measured included virus transmission rates, host support of transmission, and host survival after challenge.

Main Results:

  • A single dose of the 64TRP vaccine conferred significant protection against lethal TBEV challenge by infected ticks.
  • The 64TRP vaccine demonstrated a dual action: impairing tick blood feeding and causing tick mortality.
  • The vaccine's protective effect was comparable to a commercial TBEV vaccine, with superior transmission-blocking capabilities.

Conclusions:

  • The 64TRP anti-tick vaccine shows significant potential for controlling TBEV by interfering with pathogen transmission.
  • The vaccine's efficacy is mediated by a local immune response at the tick-feeding site, leading to impaired feeding and tick death.
  • This approach offers a promising strategy for managing vector-borne diseases by targeting the vector itself.